Literature DB >> 22037462

Adaptor protein containing PH domain, PTB domain and leucine zipper (APPL1) regulates the protein level of EGFR by modulating its trafficking.

Jae-Rin Lee1, Hwa-Sun Hahn, Young-Hoon Kim, Hong-Hoa Nguyen, Jun-Mo Yang, Jong-Sun Kang, Myong-Joon Hahn.   

Abstract

The EGFR-mediated signaling pathway regulates multiple biological processes such as cell proliferation, survival and differentiation. Previously APPL1 (adaptor protein containing PH domain, PTB domain and leucine zipper 1) has been reported to function as a downstream effector of EGF-initiated signaling. Here we demonstrate that APPL1 regulates EGFR protein levels in response to EGF stimulation. Overexpression of APPL1 enhances EGFR stabilization while APPL1 depletion by siRNA reduces EGFR protein levels. APPL1 depletion accelerates EGFR internalization and movement of EGF/EGFR from cell surface to the perinuclear region in response to EGF treatment. Conversely, overexpression of APPL1 decelerates EGFR internalization and translocation of EGF/EGFR to the perinuclear region. Furthermore, APPL1 depletion enhances the activity of Rab5 which is involved in internalization and trafficking of EGFR and inhibition of Rab5 in APPL1-depleted cells restored EGFR levels. Consistently, APPL1 depletion reduced activation of Akt, the downstream signaling effector of EGFR and this is restored by inhibition of Rab5. These findings suggest that APPL1 is required for EGFR signaling by regulation of EGFR stabilities through inhibition of Rab5.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037462     DOI: 10.1016/j.bbrc.2011.10.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

Review 1.  Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.

Authors:  Ralph A Nixon
Journal:  FASEB J       Date:  2017-07       Impact factor: 5.191

Review 2.  APPL1 is a multifunctional endosomal signaling adaptor protein.

Authors:  Nicole L Diggins; Donna J Webb
Journal:  Biochem Soc Trans       Date:  2017-06-15       Impact factor: 5.407

3.  Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function.

Authors:  Chen Wang; Xiaowen Li; Kaida Mu; Ling Li; Shihong Wang; Yunxia Zhu; Mingliang Zhang; Jiyoon Ryu; Zhifang Xie; Dongyun Shi; Weiping J Zhang; Lily Q Dong; Weiping Jia
Journal:  Diabetologia       Date:  2013-06-22       Impact factor: 10.122

4.  Altered endosome biogenesis in prostate cancer has biomarker potential.

Authors:  Ian R D Johnson; Emma J Parkinson-Lawrence; Tetyana Shandala; Roberto Weigert; Lisa M Butler; Doug A Brooks
Journal:  Mol Cancer Res       Date:  2014-07-30       Impact factor: 5.852

5.  Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer.

Authors:  J S Zhai; J G Song; C H Zhu; K Wu; Y Yao; N Li
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

6.  Experimental verification of a predicted novel microRNA located in human PIK3CA gene with a potential oncogenic function in colorectal cancer.

Authors:  Ali Jason Saleh; Bahram M Soltani; Sadat Dokanehiifard; Abdallah Medlej; Mahmoud Tavalaei; Seyed Javad Mowla
Journal:  Tumour Biol       Date:  2016-08-10

7.  APPL proteins modulate DNA repair and radiation survival of pancreatic carcinoma cells by regulating ATM.

Authors:  J Hennig; M P McShane; N Cordes; I Eke
Journal:  Cell Death Dis       Date:  2014-04-24       Impact factor: 8.469

8.  Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.

Authors:  S Kim; Y Sato; P S Mohan; C Peterhoff; A Pensalfini; A Rigoglioso; Y Jiang; R A Nixon
Journal:  Mol Psychiatry       Date:  2015-07-21       Impact factor: 15.992

9.  Multifunctional protein APPL2 contributes to survival of human glioma cells.

Authors:  Beata Pyrzynska; Magdalena Banach-Orlowska; Marta Teperek-Tkacz; Katarzyna Miekus; Grazyna Drabik; Marcin Majka; Marta Miaczynska
Journal:  Mol Oncol       Date:  2012-09-05       Impact factor: 6.603

10.  CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.

Authors:  Baocai Liu; Yu Su; Ting Li; Wanqiong Yuan; Xiaoning Mo; Henan Li; Qihua He; Dalong Ma; Wenling Han
Journal:  Oncotarget       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.